nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0346	0.0508	CcSEcCtD
Propantheline—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0335	0.0492	CcSEcCtD
Propantheline—Thirst—Furosemide—dilated cardiomyopathy	0.0249	0.0365	CcSEcCtD
Propantheline—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.0238	0.0349	CcSEcCtD
Propantheline—Confusional state—Spironolactone—dilated cardiomyopathy	0.0216	0.0316	CcSEcCtD
Propantheline—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0214	0.0314	CcSEcCtD
Propantheline—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0206	0.0302	CcSEcCtD
Propantheline—Somnolence—Spironolactone—dilated cardiomyopathy	0.019	0.0279	CcSEcCtD
Propantheline—Drowsiness—Furosemide—dilated cardiomyopathy	0.0182	0.0268	CcSEcCtD
Propantheline—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0176	0.0259	CcSEcCtD
Propantheline—Urticaria—Spironolactone—dilated cardiomyopathy	0.017	0.0249	CcSEcCtD
Propantheline—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0158	0.0231	CcSEcCtD
Propantheline—Dizziness—Spironolactone—dilated cardiomyopathy	0.0141	0.0208	CcSEcCtD
Propantheline—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.0141	0.0208	CcSEcCtD
Propantheline—Vomiting—Spironolactone—dilated cardiomyopathy	0.0136	0.02	CcSEcCtD
Propantheline—Rash—Spironolactone—dilated cardiomyopathy	0.0135	0.0198	CcSEcCtD
Propantheline—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0135	0.0198	CcSEcCtD
Propantheline—Vision blurred—Furosemide—dilated cardiomyopathy	0.0134	0.0197	CcSEcCtD
Propantheline—Headache—Spironolactone—dilated cardiomyopathy	0.0134	0.0197	CcSEcCtD
Propantheline—Nausea—Spironolactone—dilated cardiomyopathy	0.0127	0.0186	CcSEcCtD
Propantheline—Dry mouth—Furosemide—dilated cardiomyopathy	0.0119	0.0174	CcSEcCtD
Propantheline—Confusional state—Furosemide—dilated cardiomyopathy	0.0117	0.0172	CcSEcCtD
Propantheline—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0116	0.0171	CcSEcCtD
Propantheline—Flushing—Lisinopril—dilated cardiomyopathy	0.0114	0.0167	CcSEcCtD
Propantheline—Tension—Lisinopril—dilated cardiomyopathy	0.0105	0.0154	CcSEcCtD
Propantheline—Nervousness—Lisinopril—dilated cardiomyopathy	0.0104	0.0152	CcSEcCtD
Propantheline—Somnolence—Furosemide—dilated cardiomyopathy	0.0103	0.0152	CcSEcCtD
Propantheline—Vision blurred—Lisinopril—dilated cardiomyopathy	0.0101	0.0148	CcSEcCtD
Propantheline—Constipation—Furosemide—dilated cardiomyopathy	0.00995	0.0146	CcSEcCtD
Propantheline—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00959	0.0141	CcSEcCtD
Propantheline—Palpitations—Lisinopril—dilated cardiomyopathy	0.00945	0.0139	CcSEcCtD
Propantheline—Urticaria—Furosemide—dilated cardiomyopathy	0.00924	0.0136	CcSEcCtD
Propantheline—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00891	0.0131	CcSEcCtD
Propantheline—Confusional state—Lisinopril—dilated cardiomyopathy	0.0088	0.0129	CcSEcCtD
Propantheline—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00873	0.0128	CcSEcCtD
Propantheline—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00857	0.0126	CcSEcCtD
Propantheline—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00852	0.0125	CcSEcCtD
Propantheline—Asthenia—Furosemide—dilated cardiomyopathy	0.00835	0.0123	CcSEcCtD
Propantheline—CHRM1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0079	0.0248	CbGpPWpGaD
Propantheline—Insomnia—Lisinopril—dilated cardiomyopathy	0.0079	0.0116	CcSEcCtD
Propantheline—CHRM3—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00788	0.0247	CbGpPWpGaD
Propantheline—CHRM2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0078	0.0245	CbGpPWpGaD
Propantheline—Somnolence—Lisinopril—dilated cardiomyopathy	0.00776	0.0114	CcSEcCtD
Propantheline—Dizziness—Furosemide—dilated cardiomyopathy	0.00769	0.0113	CcSEcCtD
Propantheline—Constipation—Lisinopril—dilated cardiomyopathy	0.00747	0.011	CcSEcCtD
Propantheline—Vomiting—Furosemide—dilated cardiomyopathy	0.0074	0.0109	CcSEcCtD
Propantheline—Rash—Furosemide—dilated cardiomyopathy	0.00734	0.0108	CcSEcCtD
Propantheline—Dermatitis—Furosemide—dilated cardiomyopathy	0.00733	0.0108	CcSEcCtD
Propantheline—Headache—Furosemide—dilated cardiomyopathy	0.00729	0.0107	CcSEcCtD
Propantheline—CHRM1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00729	0.0229	CbGpPWpGaD
Propantheline—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00719	0.0106	CcSEcCtD
Propantheline—Urticaria—Lisinopril—dilated cardiomyopathy	0.00694	0.0102	CcSEcCtD
Propantheline—Nausea—Furosemide—dilated cardiomyopathy	0.00691	0.0101	CcSEcCtD
Propantheline—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00668	0.021	CbGpPWpGaD
Propantheline—CHRM1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00664	0.0208	CbGpPWpGaD
Propantheline—CHRM3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00662	0.0208	CbGpPWpGaD
Propantheline—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00656	0.0206	CbGpPWpGaD
Propantheline—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00643	0.00944	CcSEcCtD
Propantheline—CHRM1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0064	0.0201	CbGpPWpGaD
Propantheline—CHRM3—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00638	0.02	CbGpPWpGaD
Propantheline—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00632	0.0198	CbGpPWpGaD
Propantheline—Asthenia—Lisinopril—dilated cardiomyopathy	0.00626	0.00919	CcSEcCtD
Propantheline—Dizziness—Lisinopril—dilated cardiomyopathy	0.00577	0.00847	CcSEcCtD
Propantheline—Vomiting—Lisinopril—dilated cardiomyopathy	0.00555	0.00815	CcSEcCtD
Propantheline—Rash—Lisinopril—dilated cardiomyopathy	0.0055	0.00808	CcSEcCtD
Propantheline—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0055	0.00807	CcSEcCtD
Propantheline—Headache—Lisinopril—dilated cardiomyopathy	0.00547	0.00803	CcSEcCtD
Propantheline—CHRM1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00538	0.0169	CbGpPWpGaD
Propantheline—CHRM3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00536	0.0168	CbGpPWpGaD
Propantheline—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00531	0.0167	CbGpPWpGaD
Propantheline—Nausea—Lisinopril—dilated cardiomyopathy	0.00519	0.00761	CcSEcCtD
Propantheline—CHRM1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.005	0.0157	CbGpPWpGaD
Propantheline—CHRM3—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00499	0.0156	CbGpPWpGaD
Propantheline—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00494	0.0155	CbGpPWpGaD
Propantheline—CHRM1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00487	0.0153	CbGpPWpGaD
Propantheline—CHRM3—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00485	0.0152	CbGpPWpGaD
Propantheline—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0048	0.0151	CbGpPWpGaD
Propantheline—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00476	0.0149	CbGpPWpGaD
Propantheline—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00403	0.0127	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00402	0.0126	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00398	0.0125	CbGpPWpGaD
Propantheline—CHRM1—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00369	0.0116	CbGpPWpGaD
Propantheline—CHRM3—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00368	0.0115	CbGpPWpGaD
Propantheline—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00364	0.0114	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00361	0.0113	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00358	0.0112	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00283	0.0089	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00281	0.00881	CbGpPWpGaD
Propantheline—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00237	0.00743	CbGpPWpGaD
Propantheline—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00236	0.0074	CbGpPWpGaD
Propantheline—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00234	0.00733	CbGpPWpGaD
Propantheline—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00195	0.00613	CbGpPWpGaD
Propantheline—CHRM3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00195	0.00611	CbGpPWpGaD
Propantheline—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00193	0.00605	CbGpPWpGaD
Propantheline—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00192	0.00602	CbGpPWpGaD
Propantheline—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00191	0.006	CbGpPWpGaD
Propantheline—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00189	0.00594	CbGpPWpGaD
Propantheline—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00186	0.00583	CbGpPWpGaD
Propantheline—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.0018	0.00565	CbGpPWpGaD
Propantheline—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.0018	0.00565	CbGpPWpGaD
Propantheline—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00169	0.00532	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00169	0.0053	CbGpPWpGaD
Propantheline—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00168	0.00529	CbGpPWpGaD
Propantheline—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00168	0.00527	CbGpPWpGaD
Propantheline—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00167	0.00526	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00167	0.00525	CbGpPWpGaD
Propantheline—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00161	0.00506	CbGpPWpGaD
Propantheline—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00157	0.00494	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00157	0.00493	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00155	0.00488	CbGpPWpGaD
Propantheline—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00152	0.00479	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00152	0.00477	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00151	0.00473	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00151	0.00472	CbGpPWpGaD
Propantheline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.0015	0.00471	CbGpPWpGaD
Propantheline—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00149	0.00467	CbGpPWpGaD
Propantheline—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00148	0.00466	CbGpPWpGaD
Propantheline—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00147	0.00461	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00145	0.00455	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00145	0.00455	CbGpPWpGaD
Propantheline—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00145	0.00454	CbGpPWpGaD
Propantheline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00145	0.00454	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00143	0.0045	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00143	0.0045	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00135	0.00423	CbGpPWpGaD
Propantheline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00134	0.00422	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00133	0.00418	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00131	0.0041	CbGpPWpGaD
Propantheline—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0013	0.00409	CbGpPWpGaD
Propantheline—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0013	0.00409	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0013	0.00407	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00129	0.00405	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00129	0.00404	CbGpPWpGaD
Propantheline—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00124	0.00388	CbGpPWpGaD
Propantheline—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00123	0.00387	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00122	0.00383	CbGpPWpGaD
Propantheline—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00119	0.00375	CbGpPWpGaD
Propantheline—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00119	0.00372	CbGpPWpGaD
Propantheline—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00118	0.00371	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00112	0.0035	CbGpPWpGaD
Propantheline—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00111	0.00349	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0011	0.00347	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0011	0.00347	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0011	0.00346	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0011	0.00346	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0011	0.00346	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00109	0.00342	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00109	0.00342	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00107	0.00335	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00106	0.00333	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00106	0.00332	CbGpPWpGaD
Propantheline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00106	0.00332	CbGpPWpGaD
Propantheline—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00106	0.00331	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00104	0.00328	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00103	0.00322	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00102	0.00321	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00101	0.00318	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.001	0.00315	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000995	0.00312	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000992	0.00311	CbGpPWpGaD
Propantheline—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000987	0.0031	CbGpPWpGaD
Propantheline—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000984	0.00309	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000982	0.00308	CbGpPWpGaD
Propantheline—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000975	0.00306	CbGpPWpGaD
Propantheline—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000974	0.00306	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.000907	0.00285	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00085	0.00267	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000847	0.00266	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000839	0.00263	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000806	0.00253	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000803	0.00252	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000796	0.0025	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000785	0.00246	CbGpPWpGaD
Propantheline—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000783	0.00246	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000775	0.00243	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000736	0.00231	CbGpPWpGaD
Propantheline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000733	0.0023	CbGpPWpGaD
Propantheline—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000677	0.00212	CbGpPWpGaD
Propantheline—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000674	0.00212	CbGpPWpGaD
Propantheline—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000668	0.0021	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000624	0.00196	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000624	0.00196	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000622	0.00195	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000622	0.00195	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000616	0.00193	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000616	0.00193	CbGpPWpGaD
Propantheline—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000613	0.00192	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000598	0.00188	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000596	0.00187	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00059	0.00185	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00058	0.00182	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000579	0.00182	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000573	0.0018	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000567	0.00178	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000567	0.00178	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000565	0.00177	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000565	0.00177	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000562	0.00176	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00056	0.00176	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00056	0.00176	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00056	0.00176	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000555	0.00174	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000527	0.00165	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000525	0.00165	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00052	0.00163	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000511	0.0016	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000509	0.0016	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000505	0.00158	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000504	0.00158	CbGpPWpGaD
Propantheline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000503	0.00158	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00048	0.00151	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000479	0.0015	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000474	0.00149	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000455	0.00143	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000454	0.00143	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00045	0.00141	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000436	0.00137	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000435	0.00136	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00043	0.00135	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000414	0.0013	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000412	0.00129	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000408	0.00128	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000377	0.00118	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000376	0.00118	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000372	0.00117	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000354	0.00111	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000352	0.00111	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000349	0.0011	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000338	0.00106	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000337	0.00106	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000335	0.00105	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000335	0.00105	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000334	0.00105	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000334	0.00105	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000334	0.00105	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000331	0.00104	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000331	0.00104	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000321	0.00101	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00032	0.001	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000317	0.000995	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000311	0.000977	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00031	0.000974	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000307	0.000965	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000307	0.000963	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000306	0.00096	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000303	0.000951	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000302	0.000947	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000301	0.000944	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000298	0.000934	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000258	0.000808	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000257	0.000806	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000254	0.000798	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000246	0.000773	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000244	0.000767	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000244	0.000765	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000241	0.000757	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CD36—dilated cardiomyopathy	0.00024	0.000753	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AGT—dilated cardiomyopathy	0.000216	0.000678	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000213	0.000668	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000212	0.000666	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00021	0.00066	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00021	0.000659	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000209	0.000657	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000207	0.000651	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00019	0.000595	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000189	0.000594	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000187	0.000588	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000181	0.000569	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000181	0.000567	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000179	0.000562	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000146	0.000458	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000146	0.000457	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000144	0.000452	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000126	0.000395	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000125	0.000394	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000124	0.00039	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.63e-05	0.000271	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	8.6e-05	0.00027	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	8.51e-05	0.000267	CbGpPWpGaD
